The following are new and competing renewal awards made to faculty in the Department of Pediatrics for the month of October 2020.
Mara Becker, MD, MSCE (Rheumatology) and Danny Benjamin, MD, PhD, MPH (Infectious Diseases) received an award from National Institutes of Health/NICHD in the amount of $5,297,874 (additional $2,298,706 awarded on 9/29/20) entitled PTN2 TO#6 Clinical Pharmacokinetics and Safety Trials In Down Syndrome. The project period is 09/12/2019-06/30/2025.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Rachel Greenberg, MD, MHS (Neonatology) received an award from National Institutes of Health/NCATS in the amount of $81,680 for a project entitled HEAL Pain Supplement MFMU Network. The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) received an award from National Institutes of Health/NCATS in the amount of $75,118 for a project entitled HEAL Pain Supplement IMPACTS Network. The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Samia Aleem, MD, MHS (Neonatology) received an award from National Institutes of Health/NCATS in the amount of $488,561 for a project entitled HEAL Pain Supplement NYU Ketamine Network. The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Jason Lang, MD, MPH (Pulmonary and Sleep Medicine) received an award from National Institutes of Health/NCATS in the amount of $272,630 for a project entitled HEAL Pain Supplement Surgery PAL (Rabbits, Seattle). The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Brian Smith, MD, MPH, MHS (Neonatolgy) received an award from National Institutes of Health/NCATS in the amount of $924,758 for a project entitled HEAL Pain Supplement SKOAP (Cohen). The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Brian Smith, MD, MPH, MHS (Neonatology) received an award from National Institutes of Health/NCATS in the amount of $689,022 for a project entitled HEAL Pain Supplement RESOLVE (Debar). The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Karan Kumar, MD, MS (Critical Care Medicine) received an award from National Institutes of Health/NCATS in the amount of $377,492 for a project entitled HEAL Pain Supplement POSITIVE (Vowles, New Mexico). The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) received an award from National Institutes of Health/NCATS in the amount of $968,389 for a project entitled HEAL Pain Supplement Administrative Core. The project period is 09/15/2020-06/30/2021.
Danny Benjamin, MD, PhD, MPH (Infectious Diseases) and Brian Smith, MD, MPH, MHS (Neonatology) received an award from Technical Resources International in the amount of $44,948,186 for a project entitled ACTIV-1. The project period is 08/17/2020-08/16/2021.
Coleen Cunningham, MD (Infectious Diseases) received an award from Merck Sharp & Dohme Corp. in the amount of $108,361 for a project entitled A Phase 2 Clinical Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Doravirine/Islatravir in Adolescents with HIV-1 Infection who are Virologically Suppressed, are ≥12 to <18 Years of Age, and Weigh ≥35 kg. The project period is 11/16/2020-11/15/2022.
Michael Deel, MD (Hematology-Oncology) received an award Hyundai Hope on Wheels 2020 Scholar grant in the amount of $300,000 for a project entitled Novel Vulnerabilities within PAX3-FOX01 Transcriptional Programming for Fusion-Positive Rhabdomyosarcoma. The project period is 12/29/2020-12/31/2022.
Mohamad Mikati, MD (Neurology) received an award from Stridebio grant in the amount of $706,765 for a project entitled Optimization of Gene Therapy in Mouse Model of ATP1A3 Mutation. The project period is 10/13/2020-11/30/2022.
David Ming, MD (Hospital Medicine) received an award from Camden Coalition of Healthcare Providers in the amount of $10,000 for a project entitled Regional Complex Care Conference. The project period is 06/15/2020-04/30/2021.
Sallie Permar, MD, PhD (Infectious Diseases) and Jennifer Jenks (Molecular Genetics and Microbiology) received an award from the National Institutes of Health Fellowship award in the amount of $126,149 for a project entitled Immune Correlates of Protection Against Nonprimary Congenital Cytomegalovirus Transmission in an HIV-Infected Mother-Infant Cohort. The project period is 11/1/2020-10/31/2023.
Eliana Perrin, MD, MPH (Primary Care) received a supplement from Vanderbilt University Medical Center in the amount of $64,109 for a project entitled Greenlight Plus Study a Randomized Study of Approaches to Early Childhood Obesity Prevention –COVID-19 Supplement. The project period is 07/01/2020/06/30/2021.
Kristin Schroeder, MD, MPH (Hematology-Oncology), Nelson Chao, MD, MBA (Cell Therapy and Hematologic Malignancies) and Michael Kastan, MD, PhD (Pharmacology and Cancer Biology) received a supplement award from National Institutes of Health/NCI in the amount $199,940 for a project entitled Development of Culturally Adapted Pediatric Cancer Awareness Campaign in Tanzania. The project period is 09/08/2020-08/31/2021.
Jennifer Sherwin, MD (Critical Care Medicine) received an award from Allergan Sales, LLC in the amount of $102,574 for a project entitled A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin versus Active Comparator in Pediatric Subjects with Acute Bacterial Skin and Skin Structure Infections. The project period is from 10/01/2020-03/31/2022.
Edward Smith, MD (Neurology) received an award from Cure SMA in the amount of $52,099 for a project entitled SMA Care Center Registry. The project period is from 10/01/2020-09/30/2021.
Edward Smith, MD (Neurology) received an award from Research Triangle Institute/Sarepta Therapeutics in the amount of $217,348 for a project entitled Duchenne Early Check Newborn Screening. The project period is 01/01/2020-12/31/2022.
Edward Smith, MD (Neurology) received an award from Sarepta Therapeutics in the amount $25,912 for a project entitled Open-label comparison study of wearable devices BioStamp, AIM patch, and Actigraph as compared to ActiMyo in user preference and device performance for ambulatory DMD and LGMD patients. The project period is 09/25/2020-09/24/2021.
Emmanuel Walter, MD, MPH (Infectious Diseases) received an award from the Centers for Disease Control in the amount of $213,409 for a project entitled Clinical Vaccine Safety Evaluation-Contributing Site- Task COVID- Optional Task 3. The project period is 09/17/2020-03/31/2022.
Emmanuel Walter, MD, MPH (Infectious Diseases) received an award from Centers for Diseases Control in the amount of $8,804 for a project entitled CISA 2020-2021- Clinical Consult-0 Opt 2. The project period is 9/29/2020-09/28/2021.
Congratulations to these faculty on their awards and best wishes to them in their investigative work.
Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health